OnKure Therapeutics, Inc. (OKUR)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-105.9%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | — | $0 | — | — | — | — | — |
| Operating Income | -$62.95M | -$54.39M | -$36.93M | -$53.85M | -$39.82M | -$19.55M | — |
| Net Income | -$59.52M | -$52.67M | -$35.31M | -$51.95M | -$39.77M | -$19.46M | — |
| EPS (Diluted) | $-4.40 | $-15.28 | $-124.41 | $-2.12 | $-2.19 | $-9.60 | — |
| Total Assets | $62.12M | $114.91M | $35.73M | $108.18M | $154.02M | $55.22M | — |
| Total Liabilities | $5.93M | $11.08M | $7.75M | $8.21M | $6.81M | $4.62M | — |
| Shareholders' Equity | $56.18M | $103.83M | -$101.84M | -$54.42M | $147.21M | -$42.12M | -$23.13M |
| Cash & Equivalents | $59.05M | $110.76M | $29.88M | $19.93M | $124.66M | $53.61M | — |
| Operating Cash Flow | -$51.83M | -$51.12M | -$34.55M | -$47.36M | -$37.98M | -$18.54M | — |
| Capital Expenditures | $46.0K | $52.0K | $246.0K | $346.0K | $198.0K | $24.0K | — |
| Shares Outstanding | 13.52M | 3.45M | 283.8K | 24.50M | 18.14M | 2.03M | — |